Abstract: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit. The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3?n?p?2pr[RUX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(I) with a compound of the general formula (II) B?(HX?)s??(II). Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B?H)3?n?p?2pr[RUX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(III) with a compound of the general formula (IV) MX???(IV).

Abstract: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit. The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3?n?p?2pr[RuX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(I) with a compound of the general formula (II) B?(HX?)S.??(II) Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B?H)3?n?p?2pr[RuX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(III) with a compound of the general formula (IV) MX?.

Abstract: The invention relates to the use of a carboxy-terminal fragment of the Ki-67 protein or of an active part, fragment or homologue thereof as a compound that can be used for intracellular transfer and for the introduction in and the release by the cells. The invention further relates to transfer compounds that contain the above-mentioned Ki-67 protein and to the vectors encoding the same. The invention also relates to corresponding pharmaceutical compositions and to the use of the transfer protein as an excipient or active agent in the treatment of diseases.

Abstract: Lanthanum compounds are provided having general formulas (I) Rni+Yin? and (II) Rb+Yb? which may be used as medicaments in the prophylaxis and/or treatment of cancer diseases.

Abstract: A tumor-inhibiting platinum (II) oxalate complex and its use as a therapeutic agent are provided, in particular as a tumor-inhibiting medicament.

Abstract: The invention relates to a compound of the general formula (I) where R1, R2, R3, R4, R1?, R2?, R3? and R4? are independently of one another hydrogen, C1–C15-alkyl, C2–C15-alkenyl, C2–C15-alkinyl, C3–C16-cycloalkyl, C3–C16-cycloalkenyl, aryl or a heterocyclus which in each case can be substituted or unsubstituted, Y is a physiologically compatible anion, and n is 1 or 2, as well as its application to the prophylaxis and/or tretment of cancer illnesses.

Abstract: The present invention relates to novel indigoid binsindole derivatives which can be used for the manufacture of a medicament for the treatment of solid cancers.

Abstract: The invention relates to cerium compounds having general formulas (I) Rni+Yin? and (II) Rb+Yb+ and their application as medicaments in the prophylaxis and/or treatment of cancer diseases.

Abstract: The invention relates to cerium compounds having general formulas (I) Rni+Yin− and (II) Rb+Yb+ and their application as medicaments in the prophylaxis and/or treatment of cancer diseases.

Abstract: Lanthanum compounds are provided having general formulas (I) Rni+Yin− and (II) Rb+Yb− which may be used as medicaments in the prophylaxis and/or treatment of cancer diseases.

Abstract: The invention relates to a compound of the general formula (I) 1

Abstract: The invention relates to the use of a carboxy-terminal fragment of the Ki-67 protein or of an active part, fragment or homologue thereof as a compound that can be used for intracellular transfer and for the introduction in and the release by the cells. The invention further relates to transfer compounds that contain the above-mentioned Ki-67 protein and to the vectors encoding the same. The invention also relates to corresponding pharmaceutical compositions and to the use of the transfer protein as an excipient or active agent in the treatment of diseases.